ATG4D is the main ATG8 delipidating enzyme in mammalian cells and protects against cerebellar neurodegeneration.


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
09 2021
Historique:
received: 03 07 2020
accepted: 17 03 2021
revised: 16 03 2021
pubmed: 3 4 2021
medline: 22 3 2022
entrez: 2 4 2021
Statut: ppublish

Résumé

Despite the great advances in autophagy research in the last years, the specific functions of the four mammalian Atg4 proteases (ATG4A-D) remain unclear. In yeast, Atg4 mediates both Atg8 proteolytic activation, and its delipidation. However, it is not clear how these two roles are distributed along the members of the ATG4 family of proteases. We show that these two functions are preferentially carried out by distinct ATG4 proteases, being ATG4D the main delipidating enzyme. In mammalian cells, ATG4D loss results in accumulation of membrane-bound forms of mATG8s, increased cellular autophagosome number and reduced autophagosome average size. In mice, ATG4D loss leads to cerebellar neurodegeneration and impaired motor coordination caused by alterations in trafficking/clustering of GABA

Identifiants

pubmed: 33795848
doi: 10.1038/s41418-021-00776-1
pii: 10.1038/s41418-021-00776-1
pmc: PMC8408152
doi:

Substances chimiques

Autophagy-Related Protein 8 Family 0
Autophagy-Related Proteins 0
ATG4D protein, human EC 3.4.22.-
Cysteine Endopeptidases EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2651-2672

Subventions

Organisme : Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness)
ID : BFU2015-68539-R
Organisme : Gobierno del Principado de Asturias (Government of the Principality of Asturias)
ID : IDI/2018/000159

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Informations de copyright

© 2021. The Author(s).

Références

Marino G, Lopez-Otin C. Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell Mol Life Sci. 2004;61:1439–54.
pubmed: 15197469 pmcid: 7079832 doi: 10.1007/s00018-004-4012-4
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
pubmed: 26799652 pmcid: 4835977 doi: 10.1080/15548627.2015.1100356
Ichimura Y, Kirisako T, Takao T, Satomi Y, Shimonishi Y, Ishihara N, et al. A ubiquitin-like system mediates protein lipidation. Nature. 2000;408:488–92.
pubmed: 11100732 doi: 10.1038/35044114
Fernandez AF, Lopez-Otin C. The functional and pathologic relevance of autophagy proteases. J Clin Investig. 2015;125:33–41.
pubmed: 25654548 pmcid: 4382236 doi: 10.1172/JCI73940
Shpilka T, Weidberg H, Pietrokovski S, Elazar Z. Atg8: an autophagy-related ubiquitin-like protein family. Genome Biol. 2011;12:226.
pubmed: 21867568 pmcid: 3218822 doi: 10.1186/gb-2011-12-7-226
Marino G, Fernandez AF, Cabrera S, Lundberg YW, Cabanillas R, Rodriguez F, et al. Autophagy is essential for mouse sense of balance. J Clin Investig. 2010;120:2331–44.
pubmed: 20577052 pmcid: 2898610 doi: 10.1172/JCI42601
Nguyen N, Olivas TJ, Mires A, Jin J, Yu S, Luan L, et al. The insufficiency of ATG4A in macroautophagy. J Biol Chem. 2020;295:13584–13600.
pubmed: 32732290 doi: 10.1074/jbc.RA120.013897 pmcid: 7521654
Betin VM, Lane JD. Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J Cell Sci. 2009;122:2554–66.
pubmed: 19549685 pmcid: 2704886 doi: 10.1242/jcs.046250
Subramani S, Malhotra V. Non-autophagic roles of autophagy-related proteins. EMBO Rep. 2013;14:143–51.
pubmed: 23337627 pmcid: 3566844 doi: 10.1038/embor.2012.220
Hevers W, Luddens H. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol. 1998;18:35–86.
pubmed: 9824848 doi: 10.1007/BF02741459
Cossart R, Bernard C, Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci. 2005;28:108–15.
pubmed: 15667934 doi: 10.1016/j.tins.2004.11.011
Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL. GABAA, NMDA and AMPA receptors: a developmentally regulated ‘menage a trois’. Trends Neurosci. 1997;20:523–9.
pubmed: 9364667 doi: 10.1016/S0166-2236(97)01147-8
Reed MG, Howard CV. GSDEY One-stop stereology: the estimation of 3D parameters using isotropic rulers. J Microsc. 2010;239:54–65.
pubmed: 20579269 doi: 10.1111/j.1365-2818.2009.03356.x
Codina-Martinez H, Fernandez-Garcia B, Diez-Planelles C, Fernandez AF, Higarza SG, Fernandez-Sanjurjo M, et al. Autophagy is required for performance adaptive response to resistance training and exercise-induced adult neurogenesis. Scand J Med Sci Sports. 2020;30:238–53.
pubmed: 31650583 doi: 10.1111/sms.13586
Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006;1:581–5.
pubmed: 17406285 doi: 10.1038/nprot.2006.83
Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell. 2004;15:1101–11.
pubmed: 14699058 pmcid: 363084 doi: 10.1091/mbc.e03-09-0704
Shvets E, Fass E, Elazar Z. Utilizing flow cytometry to monitor autophagy in living mammalian cells. Autophagy. 2008;4:621–8.
pubmed: 18376137 doi: 10.4161/auto.5939
Dupont N, Leroy C, Hamai A, Codogno P. Long-Lived Protein Degradation During Autophagy. Methods Enzymol. 2017;588:31–40.
pubmed: 28237108 doi: 10.1016/bs.mie.2016.09.074
Yu ZQ, Ni T, Hong B, Wang HY, Jiang FJ, Zou S, et al. Dual roles of Atg8-PE deconjugation by Atg4 in autophagy. Autophagy. 2012;8:883–92.
pubmed: 22652539 pmcid: 3427254 doi: 10.4161/auto.19652
Tsuboyama K, Koyama-Honda I, Sakamaki Y, Koike M, Morishita H, Mizushima N. The ATG conjugation systems are important for degradation of the inner autophagosomal membrane. Science. 2016;354:1036–41.
pubmed: 27885029 doi: 10.1126/science.aaf6136
Itakura E, Kishi-Itakura C, Mizushima N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell. 2012;151:1256–69.
pubmed: 23217709 doi: 10.1016/j.cell.2012.11.001
Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720–8.
pubmed: 11060023 pmcid: 305793 doi: 10.1093/emboj/19.21.5720
Kauffman KJ, Yu S, Jin J, Mugo B, Nguyen N, O’Brien A, et al. Delipidation of mammalian Atg8-family proteins by each of the four ATG4 proteases. Autophagy. 2018;14:992–1010.
pubmed: 29458288 pmcid: 6103404
Agrotis A, Pengo N, Burden JJ, Ketteler R. Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells. Autophagy. 2019:15;976–97.
Katayama H, Kogure T, Mizushima N, Yoshimori T, Miyawaki A. A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem Biol. 2011;18:1042–52.
pubmed: 21867919 doi: 10.1016/j.chembiol.2011.05.013
McMurray MA, Thorner J. Septin stability and recycling during dynamic structural transitions in cell division and development. Curr Biol. 2008;18:1203–8.
pubmed: 18701287 pmcid: 2562167 doi: 10.1016/j.cub.2008.07.020
Takahashi Y, He H, Tang Z, Hattori T, Liu Y, Young MM, et al. An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closure. Nat Commun. 2018;9:2855.
pubmed: 30030437 pmcid: 6054611 doi: 10.1038/s41467-018-05254-w
Wang JY, Yu IS, Huang CC, Chen CY, Wang WP, Lin SW, et al. Sun1 deficiency leads to cerebellar ataxia in mice. Dis Model Mech. 2015;8:957–67.
pubmed: 26035387 pmcid: 4527285
Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364–74.
pubmed: 25975510 pmcid: 4559283 doi: 10.1016/j.tins.2015.04.003
Custer SK, Garden GA, Gill N, Rueb U, Libby RT, Schultz C, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci. 2006;9:1302–11.
pubmed: 16936724 doi: 10.1038/nn1750
Leranth C, Hamori J. “Dark” Purkinje cells of the cerebellar cortex. Acta Biol Acad Sci Hung. 1970;21:405–19.
pubmed: 4103590
Strahlendorf JC, Brandon T, Miles R, Strahlendorf HK. AMPA receptor-mediated alterations of intracellular calcium homeostasis in rat cerebellar Purkinje cells in vitro: correlates to dark cell degeneration. Neurochem Res. 1998;23:1355–62.
pubmed: 9814545 doi: 10.1023/A:1020742404945
Wang H, Bedford FK, Brandon NJ, Moss SJ, Olsen RW. GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton. Nature. 1999;397:69–72.
pubmed: 9892355 doi: 10.1038/16264
Kneussel M, Haverkamp S, Fuhrmann JC, Wang H, Wassle H, Olsen RW, et al. The gamma-aminobutyric acid type A receptor (GABAAR)-associated protein GABARAP interacts with gephyrin but is not involved in receptor anchoring at the synapse. Proc Natl Acad Sci USA. 2000;97:8594–9.
pubmed: 10900017 pmcid: 26993 doi: 10.1073/pnas.97.15.8594
Leil TA, Chen ZW, Chang CS, Olsen RW. GABAA receptor-associated protein traffics GABAA receptors to the plasma membrane in neurons. J Neurosci. 2004;24:11429–38.
pubmed: 15601949 pmcid: 6730371 doi: 10.1523/JNEUROSCI.3355-04.2004
Billard JM, Vigot R, Batini CGABA. THIP and baclofen inhibition of Purkinje cells and cerebellar nuclei neurons. Neurosci Res. 1993;16:65–69.
pubmed: 8387166 doi: 10.1016/0168-0102(93)90010-N
Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci. 2005;6:215–29.
pubmed: 15738957 doi: 10.1038/nrn1625
Egawa K, Kitagawa K, Inoue K, Takayama M, Takayama C, Saitoh S, et al. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med. 2012;4:163ra157.
pubmed: 23220633 doi: 10.1126/scitranslmed.3004655
Satoo K, Noda NN, Kumeta H, Fujioka Y, Mizushima N, Ohsumi Y, et al. The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy. EMBO J. 2009;28:1341–50.
pubmed: 19322194 pmcid: 2683054 doi: 10.1038/emboj.2009.80
Kyostila K, Syrja P, Jagannathan V, Chandrasekar G, Jokinen TS, Seppala EH, et al. A missense change in the ATG4D gene links aberrant autophagy to a neurodegenerative vacuolar storage disease. PLoS Genet. 2015;11:e1005169.
pubmed: 25875846 pmcid: 4398399 doi: 10.1371/journal.pgen.1005169
Fritschy JM, Panzanelli P, Kralic JE, Vogt KE, Sassoe-Pognetto M. Differential dependence of axo-dendritic and axo-somatic GABAergic synapses on GABAA receptors containing the alpha1 subunit in Purkinje cells. J Neurosci. 2006;26:3245–55.
pubmed: 16554475 pmcid: 6674111 doi: 10.1523/JNEUROSCI.5118-05.2006
Slemmer JE, De Zeeuw CI, Weber JT. Don’t get too excited: mechanisms of glutamate-mediated Purkinje cell death. Prog Brain Res. 2005;148:367–90.
pubmed: 15661204 doi: 10.1016/S0079-6123(04)48029-7

Auteurs

Isaac Tamargo-Gómez (I)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

Gemma G Martínez-García (GG)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

María F Suárez (MF)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

Verónica Rey (V)

Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

Antonio Fueyo (A)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
Instituto Universitario de Oncología (IUOPA), Asturias, Spain.

Helena Codina-Martínez (H)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

Gabriel Bretones (G)

Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, Oviedo, Spain.

Xurde M Caravia (XM)

Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, Oviedo, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Etienne Morel (E)

U1151 and Institut Necker Enfants-Malades, INSERM, Sorbonne Paris Cité, Université Paris Descartes, Paris, France.

Nicolas Dupont (N)

U1151 and Institut Necker Enfants-Malades, INSERM, Sorbonne Paris Cité, Université Paris Descartes, Paris, France.

Roberto Cabo (R)

Departamento de Morfología y Biología Celular, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.

Cristina Tomás-Zapico (C)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

Sylvie Souquere (S)

Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
CNRS, Villejuif, France.

Gerard Pierron (G)

Gustave Roussy Comprehensive Cancer Center, Villejuif, France.
CNRS, Villejuif, France.

Patrice Codogno (P)

U1151 and Institut Necker Enfants-Malades, INSERM, Sorbonne Paris Cité, Université Paris Descartes, Paris, France.

Carlos López-Otín (C)

Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.
Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, Oviedo, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Álvaro F Fernández (ÁF)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
Instituto Universitario de Oncología (IUOPA), Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.

Guillermo Mariño (G)

Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain. marinoguillermo@uniovi.es.
Instituto Universitario de Oncología (IUOPA), Asturias, Spain. marinoguillermo@uniovi.es.
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain. marinoguillermo@uniovi.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH